Saturday, March 14, 2009

Difficult to Reduce Proteins

Difficult to Reduce Proteins

Most proteins attain their 3D conformation, driven by the presence of cysteine amino acids, which form specific disulfide Bonds, which twist and turn the proteins to spatial conformations, many of which ultimately will react with their corresponding receptors on the cell’s surface of their receptors, thus initiating a number of biochemical cascades such us phosphorylation events , and direct trigger signals that make the cell produce specific molecules with specific functions . At times the biochemical researcher needs to reduce the protein, for a variety of reasons, weather to carry on protein sequence analysis, folding-refolding studies, protein activation, denaturation, solubilization and for other reasons.

Commonly used reducing reagents are, dithiothreitol (DTT), 2-mercaptoethanol (MCE)and 2-mercaptoethylamine, and Tris(carboxyethyl) phosphine (TCEP).

The researcher can select which reducing agent to use based upon his/her specific needs, for example, low concentrations of 2-Mercaptoethylamine•HCl are used to reduce the disulfide bridges of antibodies; on the other hand 0.5% solutions of BME are used when preparing samples for isolectric focusing applications. A good alternative to BME is DTT that can be used at concentrations ranging from 10-100mM (pH 7-9).

TCEP has the advantage of being across a larger pH range (2-11) and posses a greater redox potential as compared to DTT. In real case situations, one can run into difficult to reduce proteins, whereby one hast to use even harsher reducing conditions like 10 mM DTT and 8M urea, 4hrs ambient or 6M guanidine, 80 mM DTT, 60min at 40C, followed by alkylation.Hence you have to be careful not to carbamylate(do not heat urea)and deamidation can occur at higher temperature and pH

The following is a good reference:

Wu, J., and Watson, J. T. (1997) A novel methodology for assignment of disulfide bond pairings in proteins, Protein Sci. 6, 391-398.

Tuesday, March 10, 2009

Cobalt Inhibits the Interaction between Hypoxia Inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia Inducible Factor-α

This article reveal to us the fine points of the interaction between two unique proteins hypoxia-inducible factor (HIF) (which activates the expression of genes that contain a hypoxia response element ) and hypoxia response element (HRE) We are shown the importance of von Hippel-Lindau protein (pVHL) which mediates the ubiquitination and fast degradation of HIF (both HIF1 and 2). Proline hydroxylation (post translationally) in the oxygen dependent degradation (ODD) domain of HIF is necessary for the correct interaction between HIF and VHL. The mechanism by which cobalt mimics hypoxia, causing accumulation of HIF-1 and HIF-2 is still not well understood. The authors then show initial evidence that cobalt inhibits pVHL binding to HIF, when HIF, is hydroxylated. Removing 17 amino acids within the ODD domain of HIF-2 ( normally required for pVHL binding) inhibited cobalt binding and stabilized HIF-2, during normoxia. The authors conclude that cobalt mimics hypoxia by accessing the VHL-binding domain of HIF,and in so doing prevents HIF degradation.

Dephosphorylation and deactivation of Ca2+/calmodulin-dependent protein kinase II in bTC3-cells is mediated

This article is illustrative of how proteins phosphorylate/dephosphorylate in vivo. The authors utilized a-toxin-permeabilized bTC3 cell for the identification of protein phosphatases responsible for the dephosphorylation and deactivation of calmodulin-dependent protein kinase II (CaM kinase II) in situ.They show that an increase in calmodulin from .05 to 10 mM induced the almost-total conversion of CaM kinase II into a calmodulin-independent form typical of autophosphorylated, activated enzyme. Removing calmodulin caused CaM Kinase II to quickly go back to prestimulated levels. This observed reversal was diminished, but not prevented, by the action of inhibitors of protein phosphatase-1 (PP-1) and PP-2A, okadaic acid and calyculin A, and also by the selective chelation of Mg++ upon addition of EDTA. When both okadaic acid and EDTA were present one can observe arrest of enzyme deactivation. Then we learn that CaM kinase II phosphatase is more sensitive to calyculin A relative to okadaic acid, typical of PP-1 activity. This work hints to the fact that CaM kinase II dephosphorylation /deactivation in pancreatic b-cells is controlled by the joint action of phosphatase(okadaic acid sensitive) and PP-2C. (a Mg++- dependent phosphatase)

Conformational and Linear B-Cell Epitopes of Asp f 2, a Major Allergen of Aspergillus fumigatus

Antibodies can be generated against most commonly linear epitopes and less frequently to discontinous/conformational epitopes. In this work the authors describe Asp f 2 a major Aspergillus fumigatus (AF) allergen involved in allergic bronchopulmonary aspergillosis (ABPA). It is important to know the corresponding B-cell epitopes in order to the understandi its immunoregulation and immunodiagnosis. In order to identify the IgE binding epitopes from the linear sequence of Asp f 2, a series of decamer peptides comprising the whole molecule of Asp f 2 were synthesized on a solid support (ie; derivatized cellulose membranes) and tested IgE binding in ABPA patient and control sera. Also short synthetic peptides (three to five amino acids long) were assembled based on amino acid residues within the IgE binding regions and tested for epitope-antibody interactions. A total of nine IgE binding regions were identifed within the 268 amino acid domain and the following epitopes ,ATQRRQI, RKYFG, HWR, YTTRR, DHFAD, ALEAYA, and THEGGQ were found in the hydrophilic domain of Asp f 2. Three recombinant fragments, Asp f 2A that includes the N-terminal epitope region, Asp f 2B with no N- and C-terminal regions of the protein, and Asp f 2C comprising C-terminal epitopes, showed that either the N- or C-terminal region of the protein is necessary for the proper folding and conformation for IgE to effect antibody binding.

Base pairing involving deoxyinosine: implications for probe design

The thermal stability of oligodeoxyribonucleotide duplexes containing deoxyinoslne (1) residues matched with each of the four normal DNA bases were determined by optical melting techniques. The duplexes containing at least one I were obtained by nixing equimolar amounts of an oligonucleotide of sequence dCA3XA3G with one of sequence dCT3YT3G where X and Y were A, C, G, T, or I. Comparison of optical melting curves yielded relative stabilities for the I-containlng standard base pairs in an otherwise identical base-pair sequence. I:C pairs were found to be less stable than A:T pairs in these duplexes. Large neighboring-base effects upon stability were observed. For example, when (X,Y)=(I,A), the duplex is eight-fold more stable than when (X,Y)=(A,I). Independent of sequence effects the order of stabilities is: I:C > I:A > I:T = I:G. This order differs from that of deoxyguanosine which pairs less strongly with dA; otherwise each deoxy-lnosine base pair is less stable than its deoxyguanosine counterpart in the same sequence environment. Implications of these results for design of DNA oligonucleotide probes are discussed.

CD36 Peptides That Block Cytoadherence Define the CD36 Binding Region for Plasmodium falciparum-Infected Erythrocytes

Cell adhesion interactions are important in the understanding of various cellular processes where specific recoggition of proteín surfaces is required. Erythrocytes parasitized (PE)by P. Falciparum segregate/sequester themselves, from the circulation by adhering to microvascular endothelial cells (MEC). This segregation contributes directly to the virulence and severe pathology of malaria derived from P. falciparum; it is known that cell surface protein CD36 is an important host receptor for PE adherence, and this adhesion is mediated by the malarial variant antigen, P. falciparum erythrocyte membrane protein 1 (PfEMP1) and also by its cysteine-rich interdomain region 1 (CIDR-1). A group of peptides from the immunodominant domain of CD36 (residues 139-184) ranging in sizes from 17 to 29 amino acids, interfered with the CD36-PfEMP1 protein-protein interaction. All these peptides diminished binding at low micromolar range. Two such peptides, CD36 145-171 and CD36 156-184, selectively blocked PE adhesion to CD36 with no effect on its binding to the host receptor intercellular adhesion molecule-1 (ICAM-1).

It is also described that an adhesion blocking peptide from the ICAM-1 sequence interferes with PfEMP1– ICAM-1 interaction with no effect on its adhesion to CD36. These experiments validate earlier evidence that PfEMP1 is also a receptor for ICAM.

In summary it is shown that region 139-184 ,comprise the binding/adhesion for P. falciparum. These peptides can be be very useful for understanding the PE/PfEMP1 interaction with CD36 and for possible development of anti-adhesion molecular therapies.

Anti-angiogenin Activity of the Peptides Complementary to the Receptor-binding Site of Angiogenin

The authors describe the discovery of synthetic human angiogenic antagonists; they did so, by inferring the antisense RNA sequence codes matching to the to the receptor-binding site (RBS) of angiogenin in either 5’-3 (chANG) or 3’-5’ (chGNA) direction. These two peptides bind to angiogenin with good specificity and with a Kd of 44 nM., and in the process disrupt the interaction of angiogenin with actin, which is considered the angiogenin-binding protein on the surface of endothelial cells.These peptides block the neovascularization promoted by angiogenin in the chick chorioallantoic membrane assay (CCMA). The antagonistic activity of these peptides is angiogenin-specific, and the peptides do not seem to have an effect on embryonic angiogenesis or blood vessels already present. These peptides (chANG and chGNA) also block the angiogenesis created by the angiogenin-secreting PC 3 human prostate adenocarcinoma cells.
In conclusion, neutralization of the extracellular angiogenins secreted by PC 3 cells is achieved by the inhibition of the tumor-induced angiogenesis (peptide mediated) Therefore, chANG and chGNA synthetic peptides show potential to be effective in the treatment of angiogenin secreting human tumors.

Anthrax Toxin-Mediated Delivery In Vivo and In Vitro of a Cytotoxic T-Lymphocyte Epitope from Ovalbumin

The field of immunotherapy is a growing area where the use of synthetic peptides can be very helpful. As we all know Anthrax has received a lot of attention for its potential to be a low cost potential biochemical warfare agent. In this article the researchers describe how a non-toxic strain of anthrax toxin is able to deliver a cytotoxic T-lymphocyte (CTL) epitope in vivo, so that a unique CTL response is primed against the epitope.
This bacterial origin epitope, was then fused to the amino-terminal fragment (LFn) from the lethal-factor component of the toxin, and this chimeric protein was then injected, along with the protective antigen (PA) portion , into BALB/c mice. The authors then describe that indeed this fusion protein ( PA plus LFn) is able to deliver a different epitope, for example OVA257–264 from ovalbumin. Delivery was carried out in a different mouse haplotype, H-2Kb and took place in vitro as well as in vivo. An specific CTL clone, OVA257-264GA-4, was shown to recognize EL-4 cells treated in vitro with PA containing as little as 30 fmol of the LFn-OVA257–264 fusion protein. Also, OVA257–264-specific CTL can proliferate by incubation with splenocytes reacted with PA plus LFn-OVA257–264. In summary this work shows the potential for PA-LFn to serve as a universal delivery vehicle for CTL epitopes in vivo and also as a safe tool for the in-vitro expansion of patient-derived CTL for applications in adoptive immunotherapy.

Absolute Quantification of Specific Proteins in Complex Mixtures Using Visible Isotope-Coded

This article illustrate to us the use of a novel type of protein tagging reagent, that the authors call , “the visible isotope-coded affinity tag” (VICAT) which permits the quantification of the absolute amount of a target protein/s within a highly complex biological sample such as a eukaryotic cell lysate. This method can tag the thiol groups of cysteines or thioacetylated amino groups and also can introduce a biotin affinity handle (a visible moiety ) which allows tracking of the chromatographic position of the target peptide, without the need of a mass spectrometrer. A photocleavable linker (for tag removal) and an isotopic tag are also introduced, which enables distinguishing between the sample and reference peptides. The authors show the application of VICAT reagents to determine the absolute abundance of human group V phospholipase A2, in eukaryotic cell lysates;combining isolectric focusing of peptides on immobilized gel strip followed by microliquid chromatography/electrospray ionization mass spectrometry, they show that 66 fmol of phospholipase A2 per 100 ugs of cell protein are found in human lung macrophages. On the other hand Western blotting did not provide conclusive results. It is envisioned that VICAT reagents may be helpful for various applications including but not limited to the analysis of lead disease markers that could be detected in serum samples.

How short is short in RNAi Research

The original work of Mello and Fire from the Univ. of Massachusetts demonstrated in C. elegans, that gene expression is controlled by RNA interference (RNAi) . The initial patent applications filed by the Univ. of Massachussetts, with both Mello and Fire as the inventors, and covering this use of RNAi, clained only dsRNA longer than 25 bp’s. Later on, work done in mamalians showed that the long ds RNA was capable of inducing the release of IFN and other pro-inflammatory cytokines, causing dangerous reactions in the animals we tested. We now know that long dsRNA is recognized in the endosomes by TLRs, inducing an undesirable immune response in the animals; a situation that created a new challenge in the study of RNAi. Subsequently other researchers, such as Tuschl et.al. now at Rockefeller Univ, realized that shorter dsRNAi fragments of 25bp of smaller, while still capable of inhibiting the expression of a targeted gene, failed to induce an innate immunity response. In other words, the mammalian system is still capable of utilizing the diced dsRNA produced by the enzyme Dicer, which normally chops down the long dsRNA to sizes of 21-23 nts with 2 bases overhanging at the 3’ends of each strand. These 2 bases overhanging in dsRNA suggests that perhaps Dicer cleaves the long dsRNA in a fashion analogous to restriction enzymes. This short dsRNA can then interact with the RISC complex, where the guide strand is prepared and readied up to base pair with the target mRNA for its cleavage.

The RNAi situation is a good example of the unexpected in science. Although at the time of the initial discovery it was hard to predict that very small fragments of RNA could be pivotal in such important newly found mechanism, currently, even shorter dsRNA fragments, e.g. 15-18 bps’ are being tested. These new third generation modifiers such as LNA’s, UNA’s and others, because of their size have significant therapeutic potential.

There is a significant amount of ongoing research to elucidate the fine details of this novel gene control mechanism, including but not limited to studies of how miRNA precursors are transported to specific compartments of the cell, as these events may play important roles in the processing of the precursor by Dicer to render the active mature form of dsRNA.